Abstract
The goal of the present study was to evaluate the influence of the formulation and operating conditions on pellet preparation by pan technique. To this end, a new pelletization process, typified by the application of powdered drug on sugar-based cores using the GS coating system was studied. Inert cores were intermittently treated with micronized drug powder and adhesive solution. This treatment led to the formation of multiple layers of drug particles around an inert core resulting in the production of pellets that can further be coated by different polymers to obtain modified release formulations. Different procedures have been used to evaluate a series of important parameters such as initial core weight; speed of powder application; speed, type, and position of the atomizers; atomization degree: temperature; and air cap.
Good yield of drug layering was obtained by adjusting the quantity of both the drug powder to apply and the binder solution. Pellets obtained following the optimal operating conditions (defined in a pre-formulation study) were film coated with the acrylic polymer Eudragit L30D in order to produce a model formulation consisting of enteric polymer-coated pellets containing ibuprofen. During its preparation, the formulation showed no degradation of the drug, moreover, a low percentage of residual humidity was obtained, indicating that this system is very efficient for the production of highly stable formulations. This study showed the good performance of the GS automated pan-coating system in obtaining enteric coated pellets prepared by powder layering technique using aqueous solutions.
Keywords: Modified release pellets, powder layering, ibuprofen, enteric coated pellets
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
References
- 1.Cole G, Hogan J, Aulton M. Pharmaceutical coating technology. London: Taylor and Francis; 1995. [Google Scholar]
- 2.Armstrong NA. Tableting. In: Aulton M.E., editor. Pharmaceutics: the science of dosage form design. New York: Churchill Livingstone; 1997. [Google Scholar]
- 3.Celik M. Compaction of multiparticulate oral dosage forms. In: Ghebre-Sellasie I., editor. Multiparticulate oral drug delivery. New York: Marcel Dekker; 1994. [Google Scholar]
- 4.Bodmeier R. Tableting of coated pellets. Eur. J. Pharm. Biopharm. 1997;43:1–8. doi: 10.1016/S0939-6411(96)00028-8. [DOI] [Google Scholar]
- 5.Ragnarsson G, Johansson MOJ. Coated drug cores in multiple unit preparations: Influence of particle size. Drug Dev. Ind. Pharm. 1988;14:2285–2297. doi: 10.3109/03639048809152016. [DOI] [Google Scholar]
- 6.Flament MP, Leterme P, Gayot A, Gendrot E, Bruna E, Cousin G. Development and industrial scale-up of tablets containing modified-release pellets. Pharm. Tech. Eur. 1994;2:19–25. [Google Scholar]
- 7.Laicher A, Lorck CA, Tobin J, Stanilaus F. Process optimization of pellet coating and drying using fluidbed production units. Pharm. Tech. Eur. 1994;8:41–48. [Google Scholar]
- 8.El-Mahrouk GM, Al-Meshal MA, Al-Anagary AA, Mahrous GM. Preparation and evaluation of sustained-release indomethacin nonpareil seeds. Drug. Dev. Ind. Pharm. 1993;19:1903–1916. doi: 10.3109/03639049309073897. [DOI] [Google Scholar]
- 9.Bayomi MA, Al-Angary AA, Al-Meshal MA, El-Mahrouk GM. Preparation and dissolution characteristics of prolonged release mebeverine-HCl beads. Drug. Dev. Ind. Pharm. 1994;20:2763–2773. doi: 10.3109/03639049409042679. [DOI] [Google Scholar]
- 10.Hosny EA, El-Mahrouk GM, Gouda MW. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads. Drug. Dev. Ind. Pharm. 1998;24:661–666. doi: 10.3109/03639049809082368. [DOI] [PubMed] [Google Scholar]
- 11.The United States Pharmacopeia. Twenty-third revision. United States Pharmacopeial Convention Inc., Rockville, MD, 1995.
- 12.Ghebre-Sellasie I. In: Multiparticulate oral drug delivery. Ghebre-Sellasie I., editor. New York: Marcel Dekker; 1994. [Google Scholar]
- 13.Juslin M, Turakka L, Puumalainen P. Controlled release tables. Pharm. Ind. 1980;42:829–832. [Google Scholar]